Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Submitted by
admin
on March 12, 2018 - 9:38am
Source:
Endpoints
News Tags:
Biogen
schizophrenia
clinical trials
Pfizer
PF-04958242
Headline:
Biogen is hustling a schizophrenia drug into PhIIb after Pfizer lets it go in $590M CNS fire sale
Do Not Allow Advertisers to Use My Personal information
